Palvella Therapeutics (PVLA) Current Assets (2013 - 2026)
Palvella Therapeutics' Current Assets came in at $253.03 million for Q2 2026, up 243.1% from $73.75 million a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Palvella Therapeutics' Current Assets was $58.99 million, down 33.1% from FY2024.
- Current Assets carries a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
- Going back by year, Current Assets was $88.23 million in FY2024, $7.55 million in FY2023 (-89.7%), $73.42 million in FY2022 (-42.5%) and $127.63 million in FY2021 (+68.5%).
- The five-year range for quarterly Current Assets is $7.55 million (Q4 2023) to $263.23 million (Q1 2026).
- The fastest year-over-year change in Current Assets over five years came in Q2 2026 (growth of 243.1%), and the weakest in Q4 2023 (a decline of 89.7%).
- Business Quant data shows PVLA's Current Assets at $263.23 million (Q1 2026), $58.99 million (Q4 2025) and $66.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Palvella Therapeutics | 1.77 Bn | 1.52 Bn | - | 253.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 253.03 Mn |
| Mar 31, 2026 | 263.23 Mn |
| Dec 31, 2025 | 58.99 Mn |
| Sep 30, 2025 | 66.94 Mn |
| Jun 30, 2025 | 73.75 Mn |
| Mar 31, 2025 | 79.44 Mn |
| Dec 31, 2024 | 88.23 Mn |
| Dec 31, 2023 | 7.55 Mn |
| Sep 30, 2023 | 59.09 Mn |
| Jun 30, 2023 | 66.47 Mn |
| Mar 31, 2023 | 60.51 Mn |
| Dec 31, 2022 | 73.42 Mn |
| Sep 30, 2022 | 78.56 Mn |
| Jun 30, 2022 | 90.90 Mn |
| Mar 31, 2022 | 111.75 Mn |
| Dec 31, 2021 | 127.63 Mn |
| Sep 30, 2021 | 137.65 Mn |
| Jun 30, 2021 | 127.67 Mn |
| Mar 31, 2021 | 88.27 Mn |
| Dec 31, 2020 | 75.72 Mn |
API Access
Palvella Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();